Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ruthenium-catalyzed oxidative cleavage of olefins to aldehydes.

The Journal of organic chemistry·2001

Same author

Pharmacokinetics of testosterone after percutaneous gel or buccal administration.

Fertility and sterility·2001

Same author

The leukocyte common antigen-related protein tyrosine phosphatase receptor regulates regenerative neurite outgrowth in vivo.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2001

Same author

Calpain activity in the rat brain after transient forebrain ischemia.

Experimental neurology·2001

Same author

Sharpening low-energy, standard-model tests via correlation coefficients in neutron beta decay.

Physical review letters·2001

Same author

Creation of chimeric mutant axolotls: a model to study early embryonic heart development in Mexican axolotls.

Anatomy and embryology·2001

Search research articles

Related Experiment Video

Updated: May 18, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

Natural Modulators of Amyloid-Beta Precursor Protein Processing.

C Zhang¹, R E Tanzi

¹Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Diseases (MIND), Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 114 16th Street, Charlestown, MA, 02129-2060, USA. tanzi@helix.mgh.harvard.edu.

Current Alzheimer Research

|September 25, 2012

Summary

Natural products, especially from traditional Chinese medicine, show promise in treating Alzheimer's disease (AD) by modulating amyloid precursor protein (APP) processing, offering new therapeutic avenues for this neurodegenerative condition.

More Related Videos

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Preparation of Oligomeric β-amyloid_1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Related Experiment Videos

Last Updated: May 18, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Preparation of Oligomeric β-amyloid_1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Area of Science:

Neuroscience
Pharmacology
Biochemistry

Background:

Alzheimer's disease (AD) is a leading cause of dementia with no cure.
Amyloid-beta (Aβ) peptide accumulation in plaques drives AD pathogenesis.
Aβ is derived from the amyloid-beta precursor protein (APP) via secretase enzymes.

Purpose of the Study:

To explore how natural products influence Alzheimer's disease progression.
To elucidate the molecular mechanisms of natural product intervention in AD.
To focus on the role of natural products in modulating amyloid precursor protein (APP) processing.

Main Methods:

Review of existing literature on natural products and AD.
Analysis of studies investigating the effects of traditional Chinese medicine (TCM) on APP processing.
Examination of molecular pathways affected by natural compounds.

Main Results:

Natural products can modulate the processing of APP, a key factor in AD.
Specific TCM-derived compounds show potential in altering APP metabolism.
Understanding these mechanisms opens doors for novel therapeutic strategies.

Conclusions:

Natural products offer a promising avenue for developing new AD treatments.
Targeting APP processing with natural compounds is a viable therapeutic strategy.
Further research into TCM for AD is warranted to uncover effective molecular mechanisms.